November 19, 2008 - IntraOp Medical Corp. announced its second German order for the Mobetron, which delivers intraoperative electron-beam radiation therapy (IOERT) to cancer patients.
The University Hospital Giessen and Marburg GmbH (Marburg), located in Marburg, Germany will be the second Mobetron installation in Germany. The first is the Strahleninstitut in Cologne.
The Mobetron reportedly enables surgeons and radiation oncologists to target the exact area that requires radiation and to deliver high doses of radiation directly to the affected tissue during the cancer surgery. The mobile, self-shielded linear accelerator can move between operating rooms with ease, avoiding the high cost of building shielded vaults to accommodate traditional linear accelerators. Key patient benefits of IOERT are said to include: lower recurrence rates, increased survival rates, shorter treatment cycles and fewer side effects.
Marburg is a leading hospital for cancer care in Germany, maintaining more than 1,000 beds and conducting nearly 15,000 operations in eighteen operating theatres each year.
Professor Engenhart-Cabilic of the department for Radio-Oncology at Marburg, commented, “We are very excited to bring the Mobetron and IOERT to Marburg. By providing this form of radiation treatment to our cancer patients, we are able to offer them the best in cancer care.”
For more information: www.intraopmedical.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now